Physician profile
Daniel C Ripley
NPI 1700876893
$1,656.82
in general payments reported to CMS, 2019-2025
25 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $46.97 · 2021: $503 · 2022: $349 · 2023: $57.31 · 2024: $158 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $358.94 | 2021-2025 | Xeomin |
| Novo Nordisk INC | $238.11 | 2019-2023 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $208.35 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $161.97 | 2019-2025 | Spravato |
| Merck Sharp & Dohme LLC | $114.47 | 2021-2022 | |
| Amgen INC. | $59.36 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.78 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $42.36 | 2019-2022 | |
| Abbvie INC. | $42.15 | 2021-2022 | |
| Cms Imaging, INC. | $41.67 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.61 | 2019-2022 | |
| Medtronic Minimed, INC. | $35.93 | 2019 | |
| Allergan, INC. | $32.05 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.08 | 2022 | |
| Arbor Pharmaceuticals, INC. | $28.06 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $25.02 | 2021 | |
| Abbott Laboratories | $23.54 | 2019 | |
| Radius Health, INC. | $22.98 | 2019 | |
| Eisai INC. | $17.73 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $16.75 | 2019 | |
| Sunovion Pharmaceuticals INC. | $16.37 | 2019 | |
| Lilly USA, LLC | $15.24 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.98 | 2021 | |
| Esperion Therapeutics, INC. | $12.98 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ripley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.